Batavia: Lentivirus for first patient NL

Batavia produces lentivirus for first patient in the Netherlands successfully treated with stem cell gene therapy
Batavia Biosciences - Favicon

It is with great enthusiasm and excitement that we would like to congratulate Leiden University Medical Center and the research team on their recent accomplishment using the lentivirus. Researchers have successfully treated a baby with stem cell gene therapy for severe combined immunodeficiency disease (SCID). This form of SCID (which often claims the life of the victim before finishing their first year of life), had previously never been treated with gene therapy and now the disease has been successfully cured.

Batavia Biosciences is proud to announce that we were able to play a role in helping reduce human suffering as Batavia produced the lentivirus vector for this incredible project. Professor Frank Staal references the lentivirus vector as the “wheelbarrow that brings the gene to the right place” within the article. It’s apparent that amazing work is being done by the top names in the gene therapy field, and we are honored to be able to contribute with our expertise in viral vectors, specifically, the lentivirus in this project.

Wilfried Bakker, Director of Science and Innovation, states, “To be part of this development, we could not be prouder. Our contribution of the lentivirus vector to treat this form of SCID means a lot to us, but even more to the patient and future patients with this life-threatening form of SCID.”

Read the full press release with the links provided:

Volkskrant Article 
LUMC Press Release


New Test for Rapid and Low-cost Quality Control for Polio Vaccines

Batavia Biosciences has developed a qPCR method that can specifically detect mutations that can accumulate in poliovirus strains during vaccine production. The test demonstrates a sensitivity level highly comparable to current best practices. The novel test has been accepted for publication in the international, peer-reviewed prestigious Vaccine journal.

Viral Vector Production Guide

Bringing a new viral vector-based therapy from lab to market? This resource guides you through the complexities of viral vector development, scale-up, and cGMP manufacturing.

Low-cost viral vector manufacturing

High-throughput screening for viral vectors

Viral vector manufacturing

Thermostable viral envelope protein formulation

Maximizing protein expression